Queen Mary Hospital — Hong Kong, Hong Kong

Public research footprint of Queen Mary Hospital, compiled from the ClinicalTrials.gov public registry.

885

Registered studies

250

Active

137

Recruiting now

427

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Diffuse Large B-Cell Lymphoma · Triple Negative Breast Neoplasms · EGFR P-Loop and Alpha C-Helix Compressing

Recently updated registry entries

NCT07185997 — Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's… (Recruiting)
NCT06997497 — A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People… (Recruiting)
NCT06841354 — A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Queen Mary Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.